Company: CERO
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001213900-25-032134
Chunk: 9

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 8
Chunk 9
---
 September 30, 2024, by and between the Company and Brian G. Atwood
    (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities
    and Exchange Commission on October 2, 2024).

    10.20
     
    Consulting Agreement, dated September 30, 2024, by and between the Company and Chris Ehrlich (incorporated
    by reference to Exhibit 10.5 to the Current Report on Form 8-K filed by CERo Therapeutics Holdings, Inc. with the Securities and
    Exchange Commission on October 2, 2024).

    10.21+
     
    Employment Agreement, dated as of March 28, 2024, by and between CERo Therapeutics Holdings, Inc.
    and Charles Carter (incorporated by reference to Exhibit 10.16 to the Annual Report on Form 10-K filed by CERo Therapeutics Holdings,
    Inc. with the Securities and Exchange Commission on April 2, 2024).

    10.22+
     
    Offer Letter, dated as of March 28, 2024, by and between CERo Therapeutics Holdings, Inc. and Daniel
    Corey (incorporated by reference to Exhibit 10.17 to the Annual Report on Form 10-K filed by CERo Therapeutics Holdings, Inc. with
    the Securities and Exchange Commission on April 2, 2024).

    10.23
     
    Securities Purchase Agreement, dated as of September 25, 2024, by and between CERo Therapeutics
    Holdings, Inc. and the investors named therein (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on September 25, 2024).

    10.24
     
    Registration Rights Agreement, dated as of September 26, 2024, by and between CERo Therapeutics
    Holdings, Inc. and the investors party thereto (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed
    by CERo Therapeutics Holdings, Inc. with the Securities and Exchange Commission on September 25, 2024